SOLICITATION NOTICE
66 -- Agilent BioCel 1200/1800 Robotic Screening Platform
- Notice Date
- 8/29/2013
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support/Simplified Acquisitions, 31 Center Drive, Room 1B59, Bethesda, Maryland, 20892
- ZIP Code
- 20892
- Solicitation Number
- 2981902
- Archive Date
- 9/21/2013
- Point of Contact
- Jasmine D Snoddy, Phone: 301 594 1571
- E-Mail Address
-
snoddyj@mail.nih.gov
(snoddyj@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The solicitation number is 2981902 and the solicitation is issued as a pre-solicitation notice of intent to award a non-competitive order to Agilent Technologies, Inc., 2850 Centerville Road, Wilmington, DE, 19808-1610. This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirement of FAR Part 6-Competition Requirements. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-69, dated August 1, 2013. This acquisition is being conducted in accordance with the procedures of FAR Part 13-Simplified Acquisition Procedures. The National Center for Advancing Translational Science is requesting for the on-site field for NCATS Agilent BioCel 1200/1800 robotic automated screening platform. The Trans-NIH RNAi initiative conducts high-throughput siRNA screens in collaboration with intramural investigators. The initiative's work encompasses assay development, screening, and initial follow-up. In August 2010, a fully automated, robotic system was installed by Agilent Technologies to conduct genome-wide siRNA screens and associated operations. Since that time, NCATS have completed a number of successful genome-wide screening campaigns of this platform. Screening has revealed novel components of important cell signaling pathways and genes that affect the activity of therapeutic agents. NCATS are now embarking on many more genome-wide screens. These screens are dependent upon a number of integral parts, including the management of siRNA libraries, high throughput transfection of mammalian cells, high throughput addition of assay-specific stimuli, and high-throughput endpoint assays such as automated imaging. The period of performance is for 12 months. Agilent do not allow third party vendors to purchase or perform service on their equipment. In order to provide this necessary relocation services required for this unique and specialized custom configured system, NCATS must use the manufacturer for these specified parts, accessories and upgraded software to fully enhance the capability of this critical unit. The Defense Priorities and Allocation System (DPAS) is not applicable to this requirement. This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by September 6, 2013 3:00PM EST and must reference number 2981902. Responses may be submitted electronically to Jasmine Snoddy, Contract Specialist at Snoddyj@mail.nih.gov or by U.S. mail to the National Institute of Drug Abuse (NIDA), Station Support/Simplified Acquisition Branch (SS/SA), 31 Center Drive, Room 1B59, Bethesda, Maryland 20892-2080, Attention: Jasmine Snoddy. Fax responses will not be accepted. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency." The name and telephone number of the individual to contact for information regarding the solicitation is Jasmine Snoddy, Contract Specialist at (301) 594-1571.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-2/2981902/listing.html)
- Place of Performance
- Address: Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN03168198-W 20130831/130830000013-05356506497c282feb972d2c1bb8723e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |